Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research

Showing results (361-370 of 49,955) with videos related to

Pageof 4,996
Sort By:
Cancer Research|May 23, 2002
Adeno-associated virus protects the retinoblastoma family of proteins from adenoviral-induced functional inactivationRamesh B Batchu, Masood A Shammas, Jing Yi Wang, et al.
Cancer Research|May 31, 2002
VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cellsRanjit S Bindra, James R Vasselli, Robert Stearman, et al.
Cancer Research|May 31, 2002
Effect of germ-line genetic variation on breast cancer survival in a population-based studyEllen L Goode, Alison M Dunning, Bettina Kuschel, et al.
Cancer Research|May 31, 2002
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinomaThomas S Griffith, Jonathan M Fialkov, David L Scott, et al.
Cancer Research|May 31, 2002
Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinaseCarlos O Rodriguez, Beverly S Mitchell, Mary Ayres, et al.
Cancer Research|May 31, 2002
Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxideJun Fang, Tomohiro Sawa, Takaaki Akaike, et al.
Cancer Research|May 31, 2002
An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomasIgnacio Melero, Izaskun Gabari, Angel L Corbí, et al.
Cancer Research|May 31, 2002
Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitroJi-Yao Sun, Robert S Krouse, Stephen J Forman, et al.
Cancer Research|May 31, 2002
In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphomaJavier Briones, John Timmerman, Ronald Levy
Cancer Research|May 31, 2002
Cyclin D1 is a candidate oncogene in cutaneous melanomaEdward R Sauter, Un-Cheol Yeo, Andrea von Stemm, et al.
Pageof 4,996

Showing results (361-370 of 49,955) with videos related to

Sort By:
Pageof 4,996
Cancer Research|May 23, 2002
Adeno-associated virus protects the retinoblastoma family of proteins from adenoviral-induced functional inactivationRamesh B Batchu, Masood A Shammas, Jing Yi Wang, et al.
Cancer Research|May 31, 2002
VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cellsRanjit S Bindra, James R Vasselli, Robert Stearman, et al.
Cancer Research|May 31, 2002
Effect of germ-line genetic variation on breast cancer survival in a population-based studyEllen L Goode, Alison M Dunning, Bettina Kuschel, et al.
Cancer Research|May 31, 2002
Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinomaThomas S Griffith, Jonathan M Fialkov, David L Scott, et al.
Cancer Research|May 31, 2002
Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinaseCarlos O Rodriguez, Beverly S Mitchell, Mary Ayres, et al.
Cancer Research|May 31, 2002
Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxideJun Fang, Tomohiro Sawa, Takaaki Akaike, et al.
Cancer Research|May 31, 2002
An anti-ICAM-2 (CD102) monoclonal antibody induces immune-mediated regressions of transplanted ICAM-2-negative colon carcinomasIgnacio Melero, Izaskun Gabari, Angel L Corbí, et al.
Cancer Research|May 31, 2002
Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitroJi-Yao Sun, Robert S Krouse, Stephen J Forman, et al.
Cancer Research|May 31, 2002
In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphomaJavier Briones, John Timmerman, Ronald Levy
Cancer Research|May 31, 2002
Cyclin D1 is a candidate oncogene in cutaneous melanomaEdward R Sauter, Un-Cheol Yeo, Andrea von Stemm, et al.
Pageof 4,996